Sunmax Biotechnology Co Ltd 4728
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 231.00
- Day Range
- TWD 228.50–231.00
- 52-Week Range
- TWD 175.00–300.00
- Bid/Ask
- TWD 230.50 / TWD 231.00
- Market Cap
- TWD 12.55 Bil
- Volume/Avg
- 22,003 / 121,139
Key Statistics
- Price/Earnings (Normalized)
- 20.30
- Price/Sales
- 7.44
- Dividend Yield (Trailing)
- 4.12%
- Dividend Yield (Forward)
- 4.12%
- Total Yield
- 4.12%
Company Profile
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 67
- Website
- http://www.sunmaxbiotech.com
Comparables
Valuation
|
Metric
|
4728
|
6733
|
6929
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.30 | — | 143.34 |
Price/Book Value | 8.80 | 4.81 | 3.64 |
Price/Sales | 7.44 | 40.26 | 1.00 |
Price/Cash Flow | 17.55 | — | 10.53 |
Price/Earnings
4728
6733
6929
Financial Strength
|
Metric
|
4728
|
6733
|
6929
|
|---|---|---|---|
Quick Ratio | 2.12 | 16.25 | 0.41 |
Current Ratio | 2.36 | 17.32 | 1.24 |
Interest Coverage | 305.62 | −671.31 | 1.89 |
Quick Ratio
4728
6733
6929
Profitability
|
Metric
|
4728
|
6733
|
6929
|
|---|---|---|---|
Return on Assets (Normalized) | 30.67% | −15.44% | 0.81% |
Return on Equity (Normalized) | 47.83% | −17.18% | 2.71% |
Return on Invested Capital (Normalized) | 43.03% | −17.19% | 1.87% |
Return on Assets
4728
6733
6929
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ssyjxdyfp | Yvvjg | $572.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pcwhvxmnk | Jlxrhb | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Tnsprbh | Vwkkdk | $99.2 Bil | |
MRNA
| Moderna Inc | Fppxwbz | Rhdzn | $42.7 Bil | |
ARGX
| argenx SE ADR | Swxzlqdt | Pkm | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Tpnbfghq | Vfdc | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rmhfzvmn | Nqtrgqh | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Cbntglj | Yjwpt | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Rlfnplglc | Vxxyms | $12.7 Bil | |
INCY
| Incyte Corp | Mkgcgmn | Ppvptf | $11.9 Bil |